Brainstorm is a New York-based biotechnology company that researches and develops stem cell therapies for the treatment of neurodegenerative diseases... Read more
Brainstorm is a New York-based biotechnology company that researches and develops stem cell therapies for the treatment of neurodegenerative diseases... Read more
News
Jun 02, 2026
PR Newswire
Press Release: Brainstorm Cell Therapeutics : BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
Jun 02, 2026
BioSpace
Brainstorm Cell Therapeutics: BrainStorm levels up, bringing on former FDA leader Peter Pitts for new ALS bid
May 15, 2026
Seeking Alpha
Brainstorm Cell Therapeutics: BrainStorm Cell Therapeutics GAAP EPS of -$0.19 beats by $0.17
May 15, 2026
Benzinga
Brainstorm Cell Therapeutics: BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Apr 03, 2026
Owler
Brainstorm Cell Therapeutics, Inc.: Brainstorm Cell Therapeutics's employee count changed from 27 in Dec 2024 to 20 in Dec 2025
Mar 31, 2026
Yahoo
Brainstorm Cell Therapeutics: BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update
Mar 31, 2026
Benzinga
Brainstorm Cell Therapeutics: Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) ...
Feb 20, 2026
Seeking Alpha
Brainstorm Cell Therapeutics: Brainstorm Cell secures $1M strategic financing
Jan 02, 2026
Bloomberg Law
BrainStorm: BrainStorm Shareholder Seeks Access to Board's FDA Snub Records
Nov 14, 2025
Yahoo
BrainStorm: BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
